Home » Topics » BioWorld Science

BioWorld Science
RSS

Procter & Gamble's COX-2 inhibitor in preclinical testing

Dec. 24, 1997

RD4-6250: a potential new treatment for HCV

Dec. 24, 1997

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

Scherer, Elan extend Zydis selegiline licensing agreement

Dec. 24, 1997

Cytel initiates registration trials of Cylexin in newborns

Dec. 24, 1997

Bristol-Myers Squibb announces plans to double new product launches, overviews pipeline

Dec. 24, 1997

Company Profile: Sibia Neurosciences

Dec. 24, 1997

Efficacy of PR-000608 in mouse model of Parkinson's disease

Dec. 23, 1997

Sustiva trials now open to more AIDS patients

Dec. 23, 1997

Mechanism of antiparkinsonian activity of KW-6002 explored in mice

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026